person
Salvatore S.
- Country
- Italy
- Department
- Oncologia Falck and Ematologia
Research Overview
assignment
63
Clinical Trials ·
- Evaluation of AMG 193 Combined with Additional Therapies in Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers with Homozygous MTAP-Deletion
- Evaluation of Safety and Efficacy of Targeted Therapies in Metastatic Colorectal Cancer Subpopulations
- Evaluation of Trastuzumab Deruxtecan with Immunotherapy and Chemotherapy in First-Line Treatment of HER2-Overexpressing Advanced Non-Small Cell Lung Cancer
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
292
Sites with multiple studies
Has run more than one trial at 292 of 496 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced colorectal cancer and gastrointestinal malignancies, with particular focus on novel therapeutic approaches including targeted therapies and immunotherapy combinations.
- Colorectal Cancer Treatment Strategies
- Gastric and Esophageal Cancer Therapies
- Biliary Tract Cancer Management
Precision Medicine
Focuses on developing treatments for cancers with specific genetic alterations, including HER2-expressing tumors and those with KRAS G12C mutations.
- Molecular Targeted Therapies
- Biomarker-Driven Treatment
- Personalized Cancer Care
Therapeutic Innovation
Leads research in novel immunotherapy combinations and antibody-drug conjugates for treating various solid tumors.
- Immunotherapy Development
- Combined Modality Treatment
- Early Phase Clinical Trials
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.